Today: 3 May 2026
CoreWeave stock jumps 11% on credit-covenant relief — what CRWV investors watch next
4 January 2026
1 min read

CoreWeave stock jumps 11% on credit-covenant relief — what CRWV investors watch next

New York, Jan 4, 2026, 10:28 ET — Market closed

  • CoreWeave shares ended Friday up 10.8% after an SEC filing detailed changes to a key credit facility.
  • The AI cloud firm lowered near-term liquidity requirements and pushed out the start of certain lender tests.
  • Insider filings showed executive share sales tied largely to tax withholding on vested stock awards.

CoreWeave shares surged in the last U.S. session after the company disclosed amendments to a delayed-draw term loan facility that eased near-term liquidity requirements and delayed some covenant testing, an SEC filing showed.

The Nvidia-backed AI cloud provider’s stock closed Friday at $79.32, up $7.70, or 10.8%, after trading between $72.95 and $81.11. Volume topped 30 million shares.

The filing lands at a sensitive moment for highly leveraged “AI infrastructure” companies, which need steady hardware deliveries and customer ramp-ups to turn booked demand into cash while staying inside lender guardrails.

A covenant is a financial rule set by lenders. When companies ask to adjust covenants, equity investors often read it as a sign that timing mismatches — between spending on equipment and collecting from customers — matter as much as demand.

CoreWeave said its subsidiary and the parent entered into a “First Amendment” to the DDTL 3.0 credit agreement and a related guarantee and pledge agreement on Dec. 31. Securities and Exchange Commission

The amendment cut the “minimum liquidity amount” — cash and similar resources that must be maintained — to $100 million for monthly payment dates from March 1, 2026 through April 30, 2026, the filing said. Securities and Exchange Commission

It also postponed the first testing date for the debt service coverage ratio to Oct. 31, 2027. That ratio is a standard measure of whether cash generation can cover required debt payments.

CoreWeave added flexibility to fix covenant breaches through “equity cures,” which allow a borrower to inject equity to remedy a missed test. It can use an unlimited number of such cures for certain covenants through Oct. 28, 2026, the filing said. Securities and Exchange Commission

In the filing signed by Chief Executive Michael Intrator, the company said the amendment “aligns the facility for the timing of deliveries” described on its most recent earnings call. Securities and Exchange Commission

Separate Form 4 disclosures showed insider transactions dated Dec. 31, including sales tied to tax withholding obligations connected to vested restricted stock units, filings showed.

CoreWeave’s shares have been volatile since late 2025, when the company trimmed its annual revenue forecast after a delay at a third-party data center partner, Reuters reported at the time.

Still, covenant relief does not remove the bigger risk investors have flagged: the business remains capital intensive, and any fresh slippage in delivery schedules or customer timing can pressure liquidity even before formal covenant tests begin.

Next, investors will watch for CoreWeave’s annual report on Form 10-K for the year ended Dec. 31, 2025, where the company said it expects to file the full text of the amendment as an exhibit.

Stock Market Today

  • Manchester United (MANU) Shares Up 17.49% YTD Despite Valuation Questions
    May 2, 2026, 9:52 PM EDT. Manchester United (NYSE:MANU) shares have risen 17.49% year to date, closing at $18.54, sparking investor interest. The stock trades at a price-to-sales (P/S) ratio of 3.6x, significantly above its estimated fair value of 2.4x and more than double the US Entertainment industry average of 1.5x, suggesting a possible overvaluation. This high P/S reflects optimism about media rights, sponsorships, and matchday revenue. However, recent net income losses of £9.064 million and weaker three-year returns raise concerns. Contrarily, a discounted cash flow (DCF) model values shares at $25.11, implying a 26% discount to current price. Investors face a choice between these conflicting signals amid the club's mixed financial performance and growth prospects.

Latest article

Vertiv Stock Tests AI Data-Center Rally as VRT Shares Hit Fresh Highs

Vertiv Stock Tests AI Data-Center Rally as VRT Shares Hit Fresh Highs

3 May 2026
Vertiv shares hit a 52-week high Friday before closing at $328.31, following a 30% jump in Q1 net sales to $2.65 billion. The company raised its 2026 outlook and recently acquired Strategic Thermal Labs, expanding its liquid cooling portfolio. Investors await further details at Vertiv’s May 19-20 conference in South Carolina.
AT&T Inc. Raises $6 Billion as 5G and Fiber Bet Enters a Debt Test

AT&T Inc. Raises $6 Billion as 5G and Fiber Bet Enters a Debt Test

3 May 2026
AT&T closed a $6 billion sale of long-dated notes on April 30, with maturities ranging from 2033 to 2066, according to an SEC filing. The company reported first-quarter free cash flow of $2.5 billion, down from $3.1 billion a year earlier, citing higher capital investment. AT&T is preparing to close a $23 billion purchase of EchoStar spectrum licenses. CFO Pascal Desroches said net debt to adjusted EBITDA rose to 2.71 times.
JPMorgan Chase’s New Filing Shows the $31.4 Billion Number Investors Are Watching

JPMorgan Chase’s New Filing Shows the $31.4 Billion Number Investors Are Watching

3 May 2026
JPMorgan Chase reported first-quarter net income of $16.5 billion, up 13% from a year earlier, with revenue rising 10% to $49.8 billion. The bank’s SEC filing showed a $31.4 billion credit-loss allowance and noninterest expense up 14% to $26.9 billion. Nonperforming assets rose 10% to $10 billion. Shares closed Friday at $312.47, valuing the bank at about $864.8 billion.
AppLovin stock slides into Monday after 8% drop — what investors watch next
Previous Story

AppLovin stock slides into Monday after 8% drop — what investors watch next

Eli Lilly stock ends higher to start 2026 as traders eye JPM conference, earnings
Next Story

Eli Lilly stock ends higher to start 2026 as traders eye JPM conference, earnings

Go toTop